Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Cancer, Diabetes, Chronic Disease, and Immune Considerations People with diabetes, peripheral vascular disease, immunodeficiency, abnormal wound healing, active infection, or chronic skin disease may not respond like healthy volunteers in a topical wound model
Dosing and timing may depend on health history, lab work, treatment goals, medication use, response to treatment, cycle length, and safety risks
It is also made by the same company that made dulaglutide, making it their modern competitor to semaglutide
Until those trials are completed and reviewed, Retatrutide cannot be prescribed
US$ 22.11
US$ 29.74
US$ 25.74
US$ 25.51
